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Identity 
Other names: NRSF, XBR 
HGNC (Hugo): REST 
Location: 4q12 
Note: REST/NRSF negatively regulates the 
transcription of genes containing RE1 sites (Chong et 
al., 1995; Schoenherr and Anderson, 1995). REST has 
context dependent roles as both a tumour suppressor 
and an oncogene (Coulson, 2005). 
DNA/RNA 
Description 
The REST gene spans 24 kb of genomic DNA.  
It is composed of: three alternative 5' non-coding exons 
associated with different gene promoters, three coding 
exons, an internal alternative exon that is spliced into 
some neural and disease associated transcripts. 
Transcription 
According to Entrezgene the REST gene encodes a 
single reference sequence mRNA of 3663 bp 
(NM_005612.3) that is composed of four exons. 
However, the literature indicates that at least six
different splice variants of REST exist and are 




Schematic illustrating REST mRNA and alternative splice variants. The human REST gene is shown (top) illustrating the three main 
exons (dark blue), an alternative exon (light blue) and one of three alternative 5' non-coding exons (white). The approximate position of 
sequence encoding eight zinc fingers are illustrated by boxes, these are associated with DNA binding (white) or nuclear import (red). Six 
alternative mRNAs are illustrated below, the REST reference sequence (NM_005612.3) codes for the major isoform 1. Splice variants 
described in human *neuroblastoma (Palm et al., 1999) or **SCLC (Coulson et al., 2000) are also shown. REST 1 and REST-5F∆ code 
for isoform 2 or isoform 4 respectively. The alternative exon in REST-N62, REST-N4 and sNRSF (N50) introduces a premature stop 
codon and all three transcripts encode isoform 3 (sNRSF/REST4). 
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Schematic illustrating REST protein and alternative isoforms. Uniprot.org shows the existence of 4 REST isoforms. Isoform 1 is the 
canonical sequence; it comprises two repression domains (RD1 and RD2), lysine-rich (400-603) and proline-rich (595-815) domains, a 
DNA binding domain (159-412) of eight zinc fingers (boxes), two nuclear localization signals (shown in red), a phosphodegron 
(E1009/S1013 or S1027/S1030) and a ninth C-terminal zinc finger (1006-1082). REST can recruit a variety of transcriptional co-
repressors through interaction at RD1 or RD2; examples are illustrated including Sin3A (interaction maps to 32-122), Sin3B (43-57) and 
RCOR1 (1009-1087). Isoform 2 is truncated, retaining only zinc fingers 1-4 and localizes to the cytoplasm. Isoform 3, also called REST4 
or sNRSF, is expressed in neuroblastoma and SCLC; it lacks RD2 and has a truncated DNA binding domain, but retains zinc fingers 1-5 




Isoform 1: 1097 amino acids, 122 kDa protein, 
Isoform 2: (∆314-1097), 313 amino acids, 35 kDa 
protein, 
Isoform 3: (∆330-1097), 329 amino acids, 37 kDa 
protein, 
Isoform 4: (∆304-326), 1074 amino acids, 119 kDa 
protein. 
Expression 
REST shows specific expression patterns during 
development, and exhibits tissue-specific, cell cycle 
associated or disease dependent expression. This 
context-dependent expression of REST is regulated 
through differential transcription, splicing and 
proteasome-mediated degradation. REST is under 
expressed in differentiated neuronal tissue, however it 
plays an essential role during embryogenesis as mice 
that lack REST die by embryonic day 11.5. Although 
these mice appear normal until embryonic day 9.5, 
widespread apoptotic death then results in 
malformations in the developing nervous system and 
restricted growth (Chen et al., 1998). In other adult 
tissues, REST is ubiquitously expressed showing 
preferential accumulation in tissues of the lymphocytic 
compartment, including spleen, thymus, peripheral 
blood lymphocytes, and also in ovary (Scholl et al.,
1996). 
Localisation 
REST is predicted to localize to the nucleus, however 
the literature reports differential localization ofsome 
isoforms. REST undergoes nucleocytoplasmic 
shuttling, its nuclear targeting is dependent on either a 
classical NLS or zinc finger 5 (Shimojo et al., 2001) 
and is influenced by association with other proteins 
such as PRICKLE1 (RILP) (Shimojo and Hersh, 2003), 
HTT (Zuccato et al., 2003) and DCTN1 (p150-Glued) 
(Shimojo, 2008). REST may also be recruited to 
nuclear PML bodies by association with TRF2 (Zhang 
et al., 2008). 
Function 
REST is a transcriptional repressor with a role in 
regulating gene expression. It was identified in 1995 as 
a protein that bound to the repressor element 1 (RE1 or 
NRSE) motif, primarily located in promoter regions of 
neuron-specific genes. For this reason, REST was 
initially proposed to silence the transcription of 






Atlas Genet Cytogenet Oncol Haematol. 2011; 15(2)  210 
neuronal genes in non-neuronal cells. However, it has
subsequently emerged as both a master regulator of 
neurogenesis and a factor with other essential roles in 
both neuronal and non-neuronal cells. Indeed, 
inappropriate REST expression can trigger apoptosis 
(Lawinger et al., 2000; Neumann et al., 2004). 
A combination of bioinformatics and biochemical 
approaches has been used to identify binding sites  
and potential target genes of REST. Genome-wide 
chromatin immunoprecipitation studies have shown  
that REST can occupy several thousand RE1 motifs 
with the potential to regulate hundreds of different 
genes (Johnson et al., 2007; Otto et al., 2007). REST is 
therefore implicated in multiple biological process 
and signalling pathways, for example regulating ion
channels, growth factors or hormones, cytoskeletal 
proteins and other transcription factors (Bruce et al., 
2004). Specific examples include regulation of MAD2 
that impacts on mitosis and DNA recombination 
(Guardavaccaro et al., 2008), many neurosecretory 
proteins that affect presynaptic vesicle processing a d 
exocytosis of secreted factors (Bruce et al., 2006; Pance 
et al., 2006; D'Alessandro et al., 2009), the 
deubiquitinating enzyme UCHL1 affecting 
ubiquitination and proteasome-mediated stability 
(Barrachina et al., 2007), and the VEGF receptor NRP1 
that influences cell migration and angiogenesis 
(Kurschat et al., 2006). REST ablation impairs the 
production of laminin extracellular matrix components 
(Sun et al., 2008) and plays a role as a switch 
regulating potassium channel expression (Cheong et al., 
2005). REST also interacts with several intracellular 
signal transduction cascades, including the PI3K 
(Westbrook et al., 2005), WNT (Nishihara et al., 2003) 
and Hedgehog (Gates et al., 2010) pathways. In 
addition to directly regulating mRNA transcription, 
REST also controls expression of a family of micro-
RNAs that indirectly control other mRNA targets 
(Conaco et al., 2006), for example REST-mediated 
repression of micro-RNAs directs a switch of 
chromatin regulatory complexes essential for the 
transition to post-mitotic neurons (Yoo et al., 2009). 
REST mediates its actions through interaction with a 
large repertoire of proteins that modify chromatin 
including the transcriptional repressor SIN3A/SIN3B at 
RD1, and the methylated CpG binding protein MeCP2 
(Lunyak et al., 2002) along with many others at RD2. 
For example, the SMARCA4 (BRG1), SMARCC2 
(BAF170) and SMARCE1 (BAF57) components of the 
SWI/SNF ATP-dependent chromatin-remodeling 
complex are recruited (Battaglioli et al., 2002). RCOR1 
(coREST) is also recruited by REST to occupy RE1, 
and co-ordinates assembly of the BHC complex 
comprising the SWI/SNF component HMG20 
(BRAF35), the scaffold PHF21A (BHC80), the histone 
deacetylases HDAC1/HDAC2 and the H3K4 
demethylase KDM1A (LSD1) (Lee et al., 2005). 
Recruitment of the H3K9/H3K27 methyltransferase 
EHMT2 (G9a) (Roopra et al., 2004) appears to be 
dependent on MED12 (Ding et al., 2008) and CDYL 
(Mulligan et al., 2008). Together these complexes 
mediate transcriptional repression by remodeling 
chromatin so that histones become more tightly 
associated with DNA and less accessible to the 
transcriptional machinery (Ooi and Wood, 2007). 
Homology 
REST is a member of the mammalian family of 
Krüppel-type zinc finger transcription factors. The 




Deletions of varying size encompassing the REST 
locus on chromosome 4 were detected in one-third of 
primary human colon tumors and colon cancer cell 
lines, suggesting that chromosomal deletions targetin  
REST are a frequent event in colon cancer (Westbrook 
et al., 2005). The REST locus has also been implicated 
in brain tumors, as an amplification site identified in 
human malignant glioma mapped to chromosome 4q12 
(Schrock et al., 1994) and this region was lost in 30-
80% of oligodendrogliomas or anaplastic 
oligodendrogliomas (Zhu et al., 1998). Another study 
of 161 patients diagnosed with nervous system tumors 
also screened samples for genetic alterations in REST 
(Blom et al., 2006). Although two non-synonymous 
SNPs were found in REST exon 3, which might affect 
the capacity of REST to bind target DNA, these were 
germ line changes and no cancer-associated truncating 
or activating mutations of REST were found. The same 
study reported low-level amplification of REST in both 
glioma and medulloblastoma, although high-level 




Deletions of the chromosome 4q12, region where 
REST is located, are frequent events in colon cancer. 
Cytogenetics 
A single nucleotide deletion within REST exon 4 was 
identified in one cell line derived from colorectal 
adenocarcinoma. This results in a frameshift mutation 
and expression of REST-FS, a truncated variant with
eight zinc fingers, but lacking the C-terminal reprssion 
domain RD2 (Westbrook et al., 2005). 
Small cell lung carcinoma (SCLC) 
Note 
Altered REST function is associated with SCLC, 
because of reduced REST expression and an increased 
production of the REST splice variant sNRSF, that 
lacks part of the DNA-binding domain and the C-
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terminal repression domain RD2 (Coulson et al., 2000). 
This leads to inappropriate expression of genes like
arginine vasopressin and the glycine receptor alpha in 
SCLC (Coulson et al., 1999; Neumann et al., 2004). 
Prognosis 
For all types and stages of lung cancer diagnosed in the 
UK, the 1-year and 5-year survival is 28% and 8% 
respectively (Cancer Research UK CancerStats, 2006). 
SCG3 mRNA, a component of the REST-dependent 
neurosecretory transcriptional profile in lung cancer 
cells, was evaluated as a biomarker for noninvasive 
monitoring of neuroendocrine lung cancers and found 
to be associated with poor prognosis in limited disease 
SCLC patients (Moss et al., 2009). 
Non small cell lung carcinoma (NSCLC) 
Note 
BRM/BRG1 are integral components of the SWI/SNF 
chromatin-remodeling complex, which forms part of a 
larger repression complex associated with REST. Loss 
of BRM/BRG1 is observed in some human NSCLC 
cell lines, and leads to de-repression of REST-restricted 
genes (Watanabe et al., 2006). 
Prognosis 
Around 10% of NSCLC patients are reported to have 
BRM/BRG1 deficient lung carcinoma and this is 
associated with poor prognosis (Reisman et al., 2003; 
Fukuoka et al., 2004). 
Breast cancer 
Note 
A tumor suppressor function for REST was identified 
through an RNAi library screen for genes that 
contributed to transformation in a breast cancer model 
associated with PI3K signaling (Westbrook et al., 
2005). The TAC1 gene has been implicated in the 
development of breast and other cancers through 
production of peptides including substance P, which 
mediate resistance to apoptosis and radiation therapy. It 
was recently shown that, together with NFkB, REST 
represses TAC1 expression in mesenchymal stem cells.
However, the level of REST decreases in breast cancer 
cells and inversely correlates with substance P 
production and an aggressive cellular phenotype 
(Reddy et al., 2009). 
Prostate cancer 
Note 
Prostate tumors with a prominent neuroendocrine 
component are typically androgen independent and 
highly aggressive. In prostate adenocarcinoma cells, 
this acquisition of a neuroendocrine phenotype is 
associated with tumor progression and REST/NRSF 
levels decrease as the androgen resistance progresses. 
This directly induces IB1/JIP-1 transcription, whic in 
turn modulates the JNK signaling pathway (Tawadros 
et al., 2005). 
Medulloblastoma 
Note 
REST expression is generally low in adult brain 
permitting expression of RE1-restricted neuronal genes. 
However, REST is elevated in medulloblastoma cell 
lines and in 80% of human medulloblastoma tumors 
relatively to normal cerebellum sections, suggestiv of 
an oncogenic role. Blocking endogenous REST 
function results in neuronal gene re-expression and
apoptosis in both in vitro and in vivo medulloblastoma 
models (Lawinger et al., 2000; Fuller et al., 2005). 
Neuroblastoma 
Note 
Alternative splice variants of REST were identified in 
murine and human neuroblastoma. It was suggested 
that changes in the structure or regulation of the REST 
gene may reflect or lead to the formation and 
progression of neuroblastoma tumors, and that the 
neuronal-specific exon/flanking introns may define a 
locus of somatic recombination (Palm et al., 1999). 
Huntington's disease 
Note 
Wild type huntingtin protein (HTT) sequesters REST in 
the cytoplasm, inhibiting its function, whereas the 
mutant HTT protein cannot interact with REST 
resulting in higher levels of REST in the nucleus and 
repression of many target genes (Zuccato et al., 2007). 
Ischemia 
Note 
Global ischemia triggers REST mRNA and protein 
expression. Knockdown of the REST gene rescues 
post-ischemic neurons from ischemia-induced cell 
death in an in vitro model (Calderone et al., 2003). 
Epilepsy 
Note 
REST and the REST4 variant are differentially 
regulated in rodent hippocampal seizure models and 
correlate with expression of the proconvulsant 
substance P (Spencer et al., 2006). PRICKLE1 
(REST/NRSF interacting LIM domain protein) 
normally binds to REST mediating its translocation t  
the cytoplasm, thereby preventing REST from silencing 
target genes. A PRICKLE1 mutation identified in 
individuals with progressive myoclonus epilepsy 
blocks the PRICKLE1 and REST interaction in vitro, 
resulting in constitutively active REST and 
inappropriate downregulation of REST target genes 
(Bassuk et al., 2008). 
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